Pandion Therapeutics
Pandion is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of autoimmune and inflammatory diseases.
Business Model:
Revenue: $8.8M
Employees: 11-50
Industries / Tags:
Detailed Pandion Therapeutics Information
Pandion Therapeutics was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2021-02-25.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 134 Coolidge Avenue
City: Watertown
State: MA
Zip: 02472
Country: US
Financial Info
Stage:
series b
Raised Last:
$80M
Raised Total:$138M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Pandion is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of autoimmune and inflammatory diseases.
Contact Phone:
+16173935925
Contact Email:
Pandion Therapeutics went public on 7/16/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/16/2020
IPO Valuation:
$513M
Ticker Symbol:
PAND
IPO Price:
$18/share
Amount Raised:
$135M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Series B | 11 | $80M |
Roche Venture Fund Polaris Partners JDRF T1D Fund RA Capital Management Versant Ventures OrbiMed Mission BioCapital BioInnovation SR One Access Biotechnology Access Biotechnology Boxer Capital Roche Venture Fund Polaris Partners JDRF T1D Fund RA Capital Management Versant Ventures OrbiMed Mission BioCapital BioInnovation SR One Access Biotechnology Access Biotechnology Boxer Capital |
1/2018 | Series A | 5 | $58M |
Polaris Partners Roche Venture Fund Versant Ventures BioInnovation SR One Polaris Partners Roche Venture Fund Versant Ventures |
7/2020 | IPO | $135M |
|
12/2018 | Equity | - | 3/2020 | Series B | $80M |
Access Biotechnology Boxer Capital RA Capital OrbiMed Polaris Partners Versant Ventures SR One JDRF T1D Fund BioInnovation Capital |
12/2018 | Equity | - |
JDRF T1D Fund JDRF T1D Fund |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
